Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Eris Lifesciences Limited
ERISEris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti"diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions. It offers its products through wholesale drug distributors, and stockiest and retail pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India. Address: Shivarth Ambit, Ahmedabad, India, 380054
Analytics
WallStreetin tavoitehinta
127 785.32 INRP/E-suhde
51.0254Osinkotuotto
–Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut ERIS
Osinkoanalytiikka ERIS
Osinkojen kasvu 5 vuoden aikana
–Jatkuva kasvu
1 vuosiMaksusuhde 5 vuoden keskiarvo
29 %Osinkohistoria ERIS
Osakkeen arvostus ERIS
Talousasiat ERIS
Tuloksia | 2019 | Dynamiikka |